(182 days)
Not Found
No
The description details standard vital sign measurement technologies (PPG and sphygmomanometer) and an algorithm for blood pressure calculation, but there is no mention of AI or ML.
No
The hinscope is a spot-check vital signs measurement device used for diagnosis, not treatment.
No
This device measures vital signs (NIBP, pulse rate, SpO2) for spot-check purposes, which are indicators of the patient's current physiological state, not intended for diagnosis of a specific disease or condition. While vital signs can inform a diagnosis, the device itself is for measurement, not diagnosis. The "Intended Use" section explicitly states it is for "spot-check vital signs measurement."
No
The device description explicitly states that the device consists of both a "hinscope measurement unit" and a "hinscope mobile application." It further details that the measurement unit includes "optical sensors and a sphygmomanometer cuff," which are hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- hinscope's Function: hinscope measures vital signs (blood pressure, pulse rate, and oxygen saturation) directly from the patient's body using non-invasive methods (cuff and optical sensors). It does not analyze samples taken from the body.
The device description and intended use clearly indicate that hinscope is a vital signs monitor that interacts directly with the patient's body, not with in vitro samples.
N/A
Intended Use / Indications for Use
Hinscope is intended for spot-check vital signs measurement of adult patients in professional healthcare facilities, such as hospitals or skilled nursing facilities. It is intended to be used by trained healthcare professionals.
Hinscope is intended for spot-check measurements, in adults, of:
- · Non-Invasive Blood Pressure (NIBP)
- · Pulse rate (PR)
- · Oxygen saturation (SpO2)
Hinscope is not intended for use in high-acuity environments, such as intensive care units (ICU) or operating rooms.
Hinscope is not intended for use on acutely ill cardial to develop life-threatening arhythmias e.g. very fast atrial fibrillation. These patients should be monitored using a device with continuous electrocardiogram (ECG). Hinscope is not a substitute for an ECG monitor.
Hinscope is not intended for SpO2 and PR measurements in conditions of high motion or low perfusion.
Product codes
MSX, DXN, DOA
Device Description
hinscope consists of the:
- hinscope measurement unit
- hinscope mobile application
hinscope consists of a vital sign measurement unit, that is positioned on the patient's upper arm, and a mobile application with a user interface which allows display of the vital sign data. hinscope is a combination of optical sensors and a sphygmomanometer cuff which provide measurements of the patient's pulse rate (PR) oxygen saturation (SpO2), and non-invasive blood pressure (NIBP).
PR and SpO2 are measured using a photoplethysmography (PPG) optical measurement method. PPG is a noninvasive technology that uses light sources (green, red and infrared) and photodetectors at the surface of skin to measure the volumetric variations of blood circulation. Blood pressured with the sphygmomanometer using an algorithm in which the cuff is slowly inflated while simultaneously sensing oscillations are no longer detected, the cuff deflates rapidly, and the signals are processed to determine systolic and diastolic pressures.
The vital sign measurement device communicates with a mobile application via wireless Bluetooth Low Energy (BLE) communication. The hinlab mobile application displays the blood pressure, SpO2 and pulse rate measurements.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
patient's upper arm
Indicated Patient Age Range
Adult
Intended User / Care Setting
trained healthcare professionals / professional healthcare facilities, such as hospitals or skilled nursing facilities.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Clinical Performance Testing:
- Accuracy of blood oxygen saturation and pulse rate performance: 13 healthy adult subjects with varying BMIs and diverse skin tones. Results indicated that the SpO2 accuracy performance of hinscope passes the ARMS acceptance criteria of
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
November 14, 2024
Hinlab SAS Denys-Michel De Larouzière President 11 rue Alfred de Musset Neuilly sur Seine, 92200 France
Re: K241397
Trade/Device Name: Hinscope Regulation Number: 21 CFR 870.2300 Regulation Name: Cardiac monitor (including cardiotachometer and rate alarm). Regulatory Class: Class II Product Code: MSX, DXN, DOA Dated: May 17, 2024 Received: October 15, 2024
Dear Denys-Michel De Larouzière:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatory
2
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Stephen C. Browning -S
LCDR Stephen Browning Assistant Director Division of Cardiac Electrophysiology, Diagnostics, and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
3
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K241397
Device Name
Hinscope
Indications for Use (Describe)
Hinscope is intended for spot-check vital signs measurement of adult patients in professional healthcare facilities, such as hospitals or skilled nursing facilities. It is intended to be used by trained healthcare professionals.
Hinscope is intended for spot-check measurements, in adults, of:
- · Non-Invasive Blood Pressure (NIBP)
- · Pulse rate (PR)
- · Oxygen saturation (SpO2)
Hinscope is not intended for use in high-acuity environments, such as intensive care units (ICU) or operating rooms.
Hinscope is not intended for use on acutely ill cardial to develop life-threatening arhythmias e.g. very fast atrial fibrillation. These patients should be monitored using a device with continuous electrocardiogram (ECG). Hinscope is not a substitute for an ECG monitor.
Hinscope is not intended for SpO2 and PR measurements in conditions of high motion or low perfusion.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
| CONTINUE ON A SEPARATE PAGE IF NEEDED |
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
510(k) Summary
This 510(k) Summary is submitted in accordance with 21 CFR Part 807, Section 807.92
Submitter's Name: hinlab SAS
Submitter's Address: 11 rue Alfred de Musset 92200 Neuilly sur Seine France Telephone: +33 (0) 7 69 66 11 68
Contact Person: Denys-Michel de Larouzière Chief Executive Officer Telephone: +33 (0) 7 69 66 11 68
Date Prepared: May 10, 2024
Image /page/4/Picture/8 description: The image shows the logo for Hinlab. The logo consists of a rounded rectangle shape on the left side, with several horizontal lines inside. To the right of the shape is the word "hinlab" in lowercase letters.
5
Device Classification Information Regarding hinscope
Primary Product Code:
| Regulation
Number | Device | Medical
Specialty | Product
Code | Device
Class | Classification
Panel |
|----------------------|-----------------------------------------------------------------|----------------------|-----------------|-----------------|-------------------------|
| 870.2300 | System, Network and
Communication, Physiological
Monitors | Cardiovascular | MSX | Class 2 | Cardiovascular |
Secondary Product Codes:
| Regulation
Number | Device | Medical
Specialty | Product
Code | Device
Class | Classification
Panel |
|----------------------|-------------------------------------------------------|----------------------|-----------------|-----------------|-------------------------|
| 870.2700 | Oximeter | Cardiovascular | DQA | Class 2 | Cardiovascular |
| 870.1130 | System, Measurement, Blood-
Pressure, Non-Invasive | Cardiovascular | DXN | Class 2 | Cardiovascular |
Device Trade Name: hinscope
Device Common Name: hinscope
Indications for Use
hinscope is intended for spot-check vital signs measurement of adult patients in professional healthcare facilities, such as hospitals or skilled nursing facilities. It is intended to be used by trained healthcare professionals.
hinscope is intended for spot-check measurements, in adults, of:
- Non-Invasive blood pressure (NIBP) -
- -Pulse rate (PR)
- -Oxygen saturation (SpO2)
hinscope is not intended for use in high-acuity environments, such as intensive care units (ICU) or operating rooms. hinscope is not intended for use on acutely ill cardiac patients with the potential to develop life-threatening arrhythmias e.g. very fast atrial fibrillation. These patients should be monitored using a device with continuous electrocardiogram (ECG). hinscope is not a substitute for an ECG monitor.
hinscope is not intended for SpO2 and PR measurements in conditions of high motion or low perfusion.
Image /page/5/Picture/17 description: The image shows the logo for Hinlab. The logo consists of a rounded rectangle shape on the left, with several horizontal wavy lines inside. To the right of the shape is the word "hinlab" in a sans-serif font.
6
Summary and comparison of technological characteristics
Summary of Substantial Equivalence
The following predicate device has been that hinscope can claim equivalence with and these are detailed below.
General Comparison
| Property | Proposed Device
hinscope | Primary Predicate
Current Wearable Health
Monitoring System | Comment |
|-------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Common Name | System, Network and
Communication, Physiological
Monitors | System, Network and
Communication,
Physiological Monitors | N/A |
| Device Manufacturer | hinlab SAS | Current Health Ltd | N/A |
| Device Classification | II | II | Identical |
| 510(k) Number | K241397 | K191272 | N/A |
| Primary Product Code | MSX | MSX | Identical |
| Secondary Product
Code | DQA DXN | FLL DQA BZQ DRG BZG | Equivalent to primary
predicate for claimed
measurement
parameters |
| Target Population | Adult | Adult | Identical |
| Environment | Professional healthcare facilities | Professional healthcare
facilities & home | Equivalent. The
subject device is
intended for use in
professional healthcare
facilities, which is a
subpart of the
predicate device's
environment. There
are no safety or
effectiveness concerns
arising from these
differences. |
| Property | Proposed Device
hinscope | Primary Predicate
Current Wearable Health
Monitoring System | Comment |
| Intended
Use/Indications for Use | hinscope is intended for spot-
check vital signs measurement of
adult patients in professional
healthcare facilities, such as
hospitals or skilled nursing
facilities. It is intended to be used
by trained healthcare
professionals.
hinscope is intended for spot-
check measurements, in adults,
of:
- Non-Invasive blood pressure
(NIBP) - Pulse rate (PR)
- Oxygen saturation (SpO2)
hinscope is not intended for use in
high-acuity environments, such as
intensive care units (ICU) or
operating rooms.
hinscope is not intended for use on
acutely ill cardiac patients with the
potential to develop life-threatening arrhythmias e.g. very
fast atrial fibrillation. These
patients should be monitored using
a device with continuous
electrocardiogram (ECG).
hinscope is not a substitute for an
ECG monitor.
hinscope is not intended for SpO2
and PR measurements in
conditions of high motion or low
perfusion. | The Current Wearable Health
Monitoring System is
intended for reusable bedside,
mobile and central multi-
parameter, physiologic patient
monitoring of adult patients in
professional healthcare
facilities, such as hospitals or
skilled nursing facilities, or
their own home. It is intended
for monitoring of patients by
trained healthcare
professionals.
The Current Wearable Health
Monitoring System is
intended to provide visual and
audible physiologic multi-
parameter alarms. The Current
Wearable Health Monitoring
System is intended for
temperature monitoring where
temperature at the upper arm
is clinically indicated.
The Current Wearable Health
Monitoring System is
intended for continuous
monitoring of the following
parameters in adults:
Pulse rate
Oxygen saturation
Temperature
Movement
The Current Wearable Health
Monitoring System is
intended for intermittent or
spot-check monitoring, in
adults, of: | Equivalent. The
subject device has
similar indications as
the predicate for non-invasive blood
pressure, pulse rate
and oxygen saturation. |
| Property | Proposed Device
hinscope | Primary Predicate
Current Wearable Health
Monitoring System | Comment |
| | | Respiration rate
Non-invasive blood pressure
Lung function & spirometry
Weight
The Current Wearable Health
Monitoring System is not
intended for use on acutely ill
cardiac patients with the
potential to develop life
threatening arrhythmias e.g.
very fast atrial fibrillation. For
these patients, they should be
monitored using a device with
continuous ECG. The Current
Wearable Health Monitoring
System is not a substitute for
an ECG Monitor.
The Current Wearable Health
Monitoring System is not
intended for SpO2 monitoring
in conditions of high motion
or low perfusion. | |
Image /page/6/Picture/7 description: The image shows the logo for Hinlab. The logo consists of a rounded rectangle on the left side with horizontal wavy lines inside. To the right of the rectangle is the word "hinlab" in a sans-serif font, with a small dot above the "i".
7
Image /page/7/Picture/3 description: The image shows the logo for "hinlab". The logo consists of a rounded rectangle shape on the left side, which contains four horizontal wavy lines inside. To the right of this shape is the word "hinlab" in a simple, sans-serif font, with a small dot above the "i".
8
Device Description
hinscope consists of the:
- hinscope measurement unit
- hinscope mobile application
hinscope consists of a vital sign measurement unit, that is positioned on the patient's upper arm, and a mobile application with a user interface which allows display of the vital sign data. hinscope is a combination of optical sensors and a sphygmomanometer cuff which provide measurements of the patient's pulse rate (PR) oxygen saturation (SpO2), and non-invasive blood pressure (NIBP).
PR and SpO2 are measured using a photoplethysmography (PPG) optical measurement method. PPG is a noninvasive technology that uses light sources (green, red and infrared) and photodetectors at the surface of skin to
Image /page/8/Picture/9 description: The image shows the logo for Hinlab. The logo consists of a rounded rectangle shape on the left, with several horizontal wavy lines inside. To the right of the shape is the word "hinlab" in lowercase letters.
9
measure the volumetric variations of blood circulation. Blood pressured with the sphygmomanometer using an algorithm in which the cuff is slowly inflated while simultaneously sensing oscillations are no longer detected, the cuff deflates rapidly, and the signals are processed to determine systolic and diastolic pressures.
The vital sign measurement device communicates with a mobile application via wireless Bluetooth Low Energy (BLE) communication. The hinlab mobile application displays the blood pressure, SpO2 and pulse rate measurements.
Technological Characteristics
A comparative review of hinscope with the predicate device found that the technology, mode of operation, and general principles for treatment with this device were substantially equivalent to the predicate device.
Conclusion from nonclinical and clinical tests
Non-Clinical Tests (Performance/Physical Data)
Verification and validation activities established the safety and performance of the subject device based on the following tests, which were all passed:
| Test Name | Test Description | Results |
|---|---|---|
| Electrical Safety | hinscope was tested to confirm that it met the applicable | |
| standards for electrical safety (IEC 60601-1). | Passed | |
| EMC | hinscope was tested to confirm that it met the applicable | |
| standards for electromagnetic compatibility (EMC) (IEC 60601- | ||
| 1-2). | Passed | |
| Pulse Rate Testing | hinscope was tested to confirm the accuracy of pulse rate | |
| monitoring of the system in accordance with ISO 80601-2-61 and | ||
| the FDA Pulse Oximeters - Premarket Notification Submissions: | ||
| Guidance for Industry and FDA Staff, 2007. | Passed | |
| Usability Testing | hinscope was assessed with regards to usability for compliance | |
| with FDA Guidance Applying Human Factors and Usability | ||
| Engineering to Medical Devices. | Passed | |
| Biocompatibility Testing | Testing and analysis of hinscope has demonstrated compliance to | |
| ISO 10993-1, ISO 10993-5, ISO 10993-10 and ISO 10993-23. | Passed | |
| SpO2 Testing | Ensure the accuracy and communication of the SpO2 functions | |
| within hinscope per ISO 80601-2-61 and the FDA SpO2 | ||
| guidance: Pulse Oximeters - Premarket Notification Submissions | ||
| Guidance for Industry and Food and Drug Staff, March 4, 2013. | Passed | |
| Wireless Radio | ||
| Communication | ||
| (Wireless Coexistence) | hinscope was tested in accordance to USEMCSC C63.27-2021 | |
| and TIR69:2017/(R2020) to ensure the device can communicate | ||
| via wireless radio in its intended environment. | Passed |
Image /page/9/Picture/10 description: The image shows the logo for Hinlab. The logo consists of a rounded rectangle with horizontal lines inside, followed by the word "hinlab" in a sans-serif font. The "i" in "hinlab" has a circular dot above it.
10
Test Name Test Description Results System Verification and The system verification and validation testing was performed to Passed Validation Testing verify the software and firmware of hinscope as recommended by FDA's Guidance for Industry and FDA Staff, "Content of Premarket Submissions for Device Software Functions" (June 2023). Risk Management hinscope was tested and confirmed to meet all the applicable Passed requirements for application of risk management to medical Device per ISO 14971. Software Life Cycle hinscope was tested and confirmed to meet all the applicable Passed requirements for software life cycle per IEC 62304. Non-Invasive Blood Pressure The device was tested according to IEC 80601-2-30: Medical Passed (NIBP) Testing electrical equipment - Particular requirements for basic safety and essential performance of automated non-invasive sphygmomanometers.
hinlab SAS Traditional 510(k) For hinscope
Software Verification and Validation Testing
Software verification and validation testing were conducted, and documentation was provided as recommended by FDA's Guidance for Industry and FDA Staff, "Content of Premarket Submissions for Device Software Functions" (June 2023).
Animal Studies
No animal studies were conducted as part of submission to prove substantial equivalence.
Clinical Performance Testing
The clinical performance study investigated the accuracy of blood oxygen saturation and pulse rate performance in 13 healthy adult subjects with varying BMIs and diverse skin tones. The study was conducted in accordance with ISO 80601-2-61:2017 and Pulse Oximeters – Premarket Notifications [510(k)s] Guidance for Industry and Food and Drug Administration Staff (issued: March 4, 2013). The results of the study provide supporting evidence that the SpO2 accuracy performance of hinscope passes the ARMS acceptance criteria of